Latest News

 Filter by Provider

Investors should be prepared for the inevitable high volatility.

IntroductionChoosing a home is not only about finding the right flat. It is also about choosing the right developer and location ecosystem that supports lo

Learn how RRSP contributions work and why they are essential for Canadians approaching retirement at age 45 and beyond.

These three TFSA ideas target long-lasting Canadian trends while paying you monthly income.

The split won't change the value of shareholder holdings much.

Oaktree Capital Management saw redemption requests in its private credit fund drop by nearly half in the second quarter.

Bitcoin whale Strategy likely faces a half-point increase in its key borrowing rate as shares of its Stretch preferred stock tumble.

Unlock the potential of a TFSA to grow your wealth. Learn the key benefits and strategies for effective utilization.

Enghouse looks like a beaten-down Canadian software name where the dividend yield is now doing the selling.

Anthropic reran its "Project Fetch" robotics test and found its newer Claude models could outperform the previous generation.

Appian’s low-code automation platform serves major industries worldwide; a key insider recently trimmed their direct stake, filings show.

Joby Aviation, AST SpaceMobile, and QuantumScape are all solid long-term investments.

It's one of the best-performing Vanguard ETFs.

This monthly dividend stock has a long history of rewarding shareholders, and currently offers an attractive yield of about 4.9%.

This ETF specifically targets Canadian stocks that historically have been less volatile than the overall market.

SpaceX's public debut is reshaping ETFs, with funds from space-focused portfolios to Schwab's value ETF adding SPCX to their holdings.

These two ETFs employ very different allocation strategies.

Nvidia, Alphabet, and Tesla could all benefit from SpaceX's artificial intelligence (AI) ambitions.

This global shipping provider, known for its extensive logistics network, reported a notable insider sale amid a year of strong share gains.

Given their reliable business models, healthy cash flows, high yields, and visible growth prospects, these two Canadian dividend stocks are ideal for long-term investors.

Midwest banking specialist with over $1B in annual revenue, First Merchants reported a notable insider sale amid strong recent stock gains.

The health-conscious fast casual chain faces existential challenges.

AMD has likely risen too far, too fast.

Your wedding day is one of the most important milestones of your life, and every detail should reflect the beauty and significance of the occasion. From se

This medical device supplier, known for custom healthcare components, reported a notable insider sale amid ongoing sector diversification.

Leopold Aschenbrenner's fund holds big stakes in Nebius, CoreWeave, and IREN.

iShares Core MSCI Canadian Quality Dividend Index ETF (TSX:XDIV) stands out as an ETF worth buying up for more reasons than one!

Resilience in payouts and dividend growth makes these Canadian dividend stocks attractive investments to consider.

Rivian and Nio are screaming bargains right now.

Goldman Sachs and Morgan Stanley are organizing separate banking teams to work on potential stock market debuts by OpenAI and Anthropic.

TG Therapeutics shares are trading higher on Thursday as traders keep leaning into recent upbeat clinical updates around BRIUMVI.

Carnival shares are rising Thursday as cruise stocks benefit from falling oil after a U.S.-Iran deal to reopen the Strait of Hormuz.

Joby's suit had a setback, but Archer really took it on the chin.

The two largest energy ETFs have erased their entire Iran war rally as the Strait of Hormuz reopens. The biggest spring winners are now the worst losers.

Don't count yourself out yet. There's still time to turn things around.

Strategy’s (NASDAQ:MSTR) preferred stock has fallen to a record low, stalling the engine Michael Saylor uses to keep buying Bitcoin

SoFi Technologies shares are rising Thursday as investors react to continued insider buying from CEO Anthony Noto and a risk-on tech tape.

Owned by Berkshire Hathaway, shares in the leading bank have performed exceptionally well in the past three years.

У наш час існуе эканамічная мадэльФіксаваны даход для кожнага грамадзяніна(Я даю спасылку на артыкул па гэтай тэме — артыкул на іўрыце).Акрамя таго, як вяд

Both firms posted double-digit revenue growth in 2025, but their risk profiles and valuations diverge sharply as they chart different paths in asset management.

Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.

Sector allocations and market focus set these two international ETFs apart for investors seeking global exposure. Compare their strategies and risk profiles.

Strategy Inc. (NASDAQ:MSTR) shares are under pressure on Thursday.

Expect some big reveals in late July or early August.